SCHEMBL20149676

SCHEMBL20149676

c1ccc(-c2nccc3c2sc2cc4ccccc4cc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 3/20 0.43
PDE3A Q14432 3/20 0.43
HTR2B P41595 2/20 0.38
HTR5A P47898 2/20 0.38
TDO2 P48775 1/20 0.38
KDM4E B2RXH2 4/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
GPR55 Q9Y2T6 1/20 0.38
MAPT P10636 3/20 0.37
KMT2A Q03164 2/20 0.37
GLA P06280 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
BCHE P06276 2/20 0.36
LIMK1 P53667 2/20 0.36
NQO2 P16083 1/20 0.35
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
CDK5 Q00535 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542602 0.86 ADORA2A (0.34) PDE3BPDE3AHTR2BHTR5ATDO2
SCHEMBL24795852 0.81 HTR2B (0.45) PDE3BPDE3AHTR2BHTR5ATDO2
SCHEMBL17640479 0.78 LIMK1 (0.45) PDE3BPDE3AHTR2BHTR5ATDO2
SCHEMBL20137415 0.78 MAPT (0.44) L3MBTL1MAPTMAPK1ALDH1A1CYP3A4
SCHEMBL24118989 0.78 CYP2A6 (0.44) PDE3BPDE3ATDO2KDM4ENPC1
SCHEMBL11941250 0.78 ESR1 (0.41) PDE3BPDE3AHTR2BHTR5ATDO2
SCHEMBL25545911 0.78 KDM4E (0.31) HTR2BHTR5AKDM4ENPC1RAB9A
SCHEMBL27057572 0.77 PDE3B (0.35) PDE3BPDE3AHTR2BHTR5ATDO2
SCHEMBL17640482 0.74 LIMK1 (0.47) PDE3BPDE3AHTR2BHTR5ATDO2
SCHEMBL23972156 0.74 KDM4E (0.40) PDE3BPDE3AHTR2BHTR5ATDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3354654-B1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2022-04-27 EP disclosed
US-20210343950-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2021-11-04 US disclosed
US-11069864-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-07-20 US disclosed
US-20200251669-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2020-08-06 US disclosed
US-10680188-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-06-09 US disclosed
EP-3354654-A2 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2018-08-01 EP disclosed
US-20180138427-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed
US-20180138427-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10680188-B2 Organic electroluminescent materials and devices AOX1, OCIAD1, OCIAD2 PDE3B 3066/4885PDE3A 3940/4885HTR2B 1824/4885
US-20200251669-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES AOX1, OCIAD1, OCIAD2 PDE3B 3066/4885PDE3A 3940/4885HTR2B 1824/4885
US-20210343950-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES AOX1, OCIAD1, OCIAD2 PDE3B 3066/4885PDE3A 3940/4885HTR2B 1824/4885
US-20180138427-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES AOX1, OCIAD1, OCIAD2 PDE3B 3066/4885PDE3A 3940/4885HTR2B 1824/4885
US-11069864-B2 Organic electroluminescent materials and devices AOX1, OCIAD1, OCIAD2 PDE3B 3066/4885PDE3A 3940/4885HTR2B 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.